3D skin analysis vs 2D multispectral, where the difference really lies

When a practice decides on a skin analysis method today, two technical families compete: 2D multispectral (VISIA, Observ) and 3D topography (Antera 3D, Isemeco D8/D9). Both measure skin parameters. Both produce colourful reports. Both are marketed as "digital skin analysis". The technical difference gets glossed over in sales pitches, we walk through it along four report areas.

What 2D multispectral actually measures

A VISIA device takes eight to twelve photos in sequence, each under different illumination: white light, polarised light parallel and crossed, UV light. From these images, specific skin features are extracted by analysing light reflection in different skin layers. UV light reveals pigment changes invisible in normal daylight. Polarisation toggling separates surface wrinkles from deeper pigment disorders.

What VISIA cannot measure: the three-dimensional shape of the skin. A wrinkle is detected via shadows and light reflection, its actual depth is an estimate, not a measurement. For very fine wrinkles or very deep, sharply demarcated furrows, the estimate is systematically off.

What 3D topography actually measures

Antera 3D and Isemeco D8/D9 reconstruct a true 3D mesh of the skin surface from multiple captures under varying illumination angles. The result is a geometry of tens of thousands of triangles whose Z-coordinate describes the actual height or depth at each location in micrometres. Only on this mesh do the same illumination-based analyses run as on 2D devices.

What this means practically: a wrinkle measurement in 3D is a geometric measurement. The skin value "crow's feet 3.2 mm deep, 12 mm long" is reproducible at the micrometre level. The equivalent 2D measurement is a relative position against a reference database.

Where the difference really shows

1. Wrinkle assessment

3D clearly ahead. If you document before/after comparisons for Botox, filler or ablative laser, you need quantifiable depth values. 2D delivers a qualitative observation ("visibly less"), 3D delivers a numerical measurement ("wrinkle volume changed by 0.42 mm³"). The latter is solid as treatment documentation in the patient record. Neither statement is an outcome promise toward the patient, that would be prohibited under both the HWG (§ 11) and the professional code of conduct.

2. Pigment (visible spots)

2D slightly ahead. Pigment is a surface phenomenon arising primarily from light absorption at melanin clusters. 2D multispectral is fully sufficient here and often sharper in cluster detection. 3D devices do the same pigment detection, but the extra 3D reconstruction effort adds little for this parameter.

3. UV markers (hidden pigment changes)

Both methods on par. UV captures under 365 nm light reveal pigment clusters in the upper skin layers invisible under normal light. This works equally well in 2D and 3D. The 3D advantage here is only that UV findings map onto the same mesh model as wrinkle findings, the same patient with multiple concerns can be documented in a single session.

4. Skin contour and volume

3D clearly ahead, 2D practically unable. When you document volume-providing treatments (hyaluronic acid filler, fat transfer, dermal-augmenting microneedling), quantifiable contour measurement is the most important parameter. 2D devices cannot do this, contour is the Z-axis of 3D topography, missing in a 2D photo. Practices working aesthetically and substantiating patient expectations with numbers need 3D.

Which combination makes sense

We see three practice types with different optimal setups.

• General dermatology practice (pigment, skin cancer screening, acne, rosacea): VISIA or Observ are enough. 2D multispectral is cheaper and faster, and findings match indication.
• Aesthetic anti-aging practice with volume treatments: 3D is mandatory. Antera 3D or Isemeco D8/D9, depending on throughput and budget.
• Mixed practice (50/50): Use a 3D device, it covers 2D functionality too. The reverse doesn't work, a VISIA does not produce 3D.

What to avoid as a practice

Vendor promises like "3D AI skin analysis" or "AI-powered 4D" are often terminology gymnastics. The points below decide in reality but rarely appear in brochures:

• What's the depth resolution in micrometres? VISIA 0, Antera 3D ~30–50 µm, Isemeco D9 ~20–40 µm.
• What's the capture area? VISIA full face, Antera individual 50 × 50 mm patches, Isemeco full face.
• How reproducible is a before/after capture? VISIA depends heavily on positioning; 3D devices normalise internally via anatomical markers.
• Who runs the analysis, the device or an external cloud service? Cloud services outside the EU are problematic under GDPR (see our GDPR article).